Interestingly, also two excised, patient-derived cholangiocarcinoma xenografts were analyzed and revealed strong IMP2 and p62 expression and a distinct tumor growth (Supplementary Figure 3). The gene discussed is IGF2BP2; the disease is neoplasm.